Search Results - "Tipanee, Jaitip"
-
1
Transposons: Moving Forward from Preclinical Studies to Clinical Trials
Published in Human gene therapy (01-11-2017)“…Transposons have emerged as promising vectors for gene therapy that can potentially overcome some of the limitations of commonly used viral vectors…”
Get more information
Journal Article -
2
Preclinical and clinical advances in transposon-based gene therapy
Published in Bioscience reports (22-12-2017)“…Transposons derived from (SB), (PB), or typically require cotransfection of transposon DNA with a transposase either as an expression plasmid or mRNA…”
Get full text
Journal Article -
3
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
Published in Nucleic acids research (19-09-2018)“…Abstract CRISPR/Cas9 is an attractive platform to potentially correct dominant genetic diseases by gene editing with unprecedented precision. In the current…”
Get full text
Journal Article -
4
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
Published in Molecular therapy. Nucleic acids (06-03-2020)“…We established a semi-high-throughput in vivo screening platform using hyperactive piggyBac (hyPB) transposons (designated as PB-miR) to identify microRNAs…”
Get full text
Journal Article -
5
UNIVERSAL ALLOGENEIC CAR T CELLS ENGINEERED WITH SLEEPING BEAUTY TRANSPOSONS AND CRISPR/CAS9 FOR CANCER IMMUNOTHERAPY
Published in Molecular therapy (05-10-2022)“…Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T cell receptor (TCR) expression can be used as an ‘off-the-shelf’…”
Get full text
Journal Article -
6
Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma
Published in Tumor biology (01-09-2016)“…Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the members of hepatobiliary diseases. Both types of cancer often exert high levels of…”
Get full text
Journal Article -
7
Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes
Published in Molecular therapy (05-01-2022)“…CTG repeat expansion (CTGexp) is associated with aberrant alternate splicing that contributes to cardiac dysfunction in myotonic dystrophy type 1 (DM1)…”
Get full text
Journal Article